2024-11-06 REL RCSB RCSB RCSB 2022-01-24 2022-02-09 2022-02-09 2024-11-06 National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) AI145687 United States National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) AI165147 United States Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D6 state Gobeil S Acharya P SARS-CoV-2 Spike Protein Trimer, VIRAL PROTEIN Gobeil SM Henderson R Stalls V Janowska K Huang X May A Speakman M Beaudoin E Manne K Li D Parks R Barr M Deyton M Martin M Mansouri K Edwards RJ Eaton A Montefiori DC Sempowski GD Saunders KO Wiehe K Williams W Korber B Haynes BF Acharya P Structural diversity of the SARS-CoV-2 Omicron spike. Mol.Cell US 82 2050 2068.e6 2022 35447081 doi:10.1016/j.molcel.2022.03.028 1097-2765 2168 MOCEFL 7toy FULLOVERLAP Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D6 state Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D6 state 0 1 Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein Severe acute respiratory syndrome coronavirus 2 0.142244328 3 Homo sapiens LEVO MFVFLVLLPLVSSQCVNLRTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFD NPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLDVYYHKNNKSWMESGVYSS ANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLL ALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQP TESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVI RGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYRYRLFRKSNLKPFERDISTEIYQAGSKPCNG VEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPF QQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNV FQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSRGSASSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISV TTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNF SQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTI TSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQNVVNQNAQALNTL VKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDF CGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFV SGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQE LGKYEQGSGYIPEAPRDGQAYVRKDGEWVLLSTFLGRSLEVLFQGPGHHHHHHHHSAWSHPQFEKGGGSGGGGSGGSAWS HPQFEK P0DTC2 2-acetamido-2-deoxy-beta-D-glucopyranose 0.000221208 33 NAG singleParticle particle 1.5 8.0 ETHANE FEI TITAN KRIOS OTHER BRIGHT FIELD FIELD EMISSION GUN 300 0.75 2.5 GATAN K3 (6k x 4k) 55.0 1 7KDK 3.53 FSC 0.143 CUT-OFF 98277 NOT APPLICABLE NOT APPLICABLE emd_26041.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 300 300 300 0 0 0 300 300 300 324.0 324.0 324.0 90.0 90.0 90.0 X Y Z -0.98491997 3.4613223 -0.0038755427 0.13831867 1.08 1.08 1.08 0.8 AUTHOR Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D6 state 7KDK PDB experimental model AB INITIO MODEL